Clinical Trials Logo

Anxiety Disorders clinical trials

View clinical trials related to Anxiety Disorders.

Filter by:

NCT ID: NCT03845101 Not yet recruiting - Clinical trials for Social Anxiety Disorder

CBT Versus CBT Augmented With Virtual Reality Exposure for Social Anxiety Disorder.

SO-REAL
Start date: March 2, 2019
Phase: N/A
Study type: Interventional

Background Social Anxiety Disorder has high lifetime prevalence, early onset and long duration or chronicity. Exposure therapy is considered as one of the most effective element in cognitive behavioural therapy but in vivo exposure can be difficult to access and control, and is sometimes rejected by patients because they consider it too aversive. The use of virtual reality allows exposure to challenging situations in an immersive, but also protected, flexible and controlled environment. Aim The aim of the SO REAL-trial is to investigate the effect of cognitive behavioural therapy (CBT-In Vivo Exposure) versus cognitive behavioural therapy augmented with virtual reality exposure (CBT-Virtual Exposure) for patients diagnosed with social anxiety disorder. Methods The design is an investigator initiated randomized, assessor-blinded, parallel group and superiority designed clinical trial. From the psychotherapeutic outpatient clinics at Mental Health Centre Copenhagen, 302 patients, diagnosed with social anxiety disorder, will be included. All patients will be offered a manual-based 14 week cognitive behavioural treatment program, including 8 sessions with exposure therapy. Patients will be centrally randomised with concealed allocation sequence to cognitive behavioural therapy augmented with virtual reality exposure or cognitive behavioural therapy. Patients will be assessed at baseline, post treatment and at one-year follow-up by independent researchers blinded for treatment condition. The primary outcome will be social anxiety measured with Liebowitz Social Anxiety Scale. Secondary outcome measures will include depression, social functioning, and patient satisfaction. Exploratory outcomes will be substance and alcohol use, working alliance, quality of life. Perspectives The SO REAL trial will be the hitherto largest trial investigating the use of virtual reality as augmentation of cognitive behavioural therapy and the results may guide future clinical treatment

NCT ID: NCT03844659 Recruiting - Clinical trials for Anxiety and Satisfaction

Music's Effects on Anxiety During Epidural Placement

Start date: October 19, 2018
Phase: N/A
Study type: Interventional

The objective of the study is to determine if playing the song "Weightless" by Marconi Union during labor epidural placement, decreases laboring parturient anxiety and improves satisfaction with the experience.

NCT ID: NCT03838835 Recruiting - Anxiety Clinical Trials

Equine Facilitated CBT Group Therapy for Youth Anxiety

Start date: November 15, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate a 10-week equine facilitated cognitive behavioral therapy (CBT) group program for youth between ages of 6 to 17 with symptoms of anxiety. The program will be delivered at GallopNYC, a stable that provides equine-facilitated group therapy to youth with a range of mental health problems.

NCT ID: NCT03838081 Completed - Dental Anxiety Clinical Trials

Evaluation on the Anxiety of Third Molar Extraction

Start date: September 15, 2018
Phase: N/A
Study type: Interventional

This study was performed on 66 patients who were admitted for third molar extraction under local anesthesia. The patients were divided into three groups: group 1 with verbal information, group 2 with written information, and group 3 with previous surgical experience. Spielberger State Anxiety Inventory (STAI-S), Dental Fear Scale (DFS), Modified Dental Anxiety Scale (MDAS), and Visual Analog Scale (VAS) were used pre- and postoperatively to evaluate dental anxiety

NCT ID: NCT03837392 Recruiting - Clinical trials for Post Partum Depression

Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Depression

Start date: February 18, 2019
Phase: N/A
Study type: Interventional

This protocol will test the hypothesis that Acceptance and Commitment Therapy (ACT) is effective in reducing depressive and anxiety symptoms during the perinatal and postpartum periods. Participants should expect their participation in the study to last 9-12 months.

NCT ID: NCT03829241 Not yet recruiting - Clinical trials for Generalized Anxiety Disorder

Randomized Trial of Adult Subjects With Generalized Anxiety Disorder

Start date: February 20, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy of BHV-4157 versus placebo in subjects with Generalized Anxiety Disorder.

NCT ID: NCT03828760 Not yet recruiting - Pain, Acute Clinical Trials

The Effectiveness of Music on Pain and Anxiety in IUD Insertion

Start date: March 2019
Phase: N/A
Study type: Interventional

Although intrauterine devices (IUDs) are a highly effective contraceptive method, fear of pain during insertion is one barrier to use. A review of literature reveals little investigation of interventions for anxiety management during the procedure. Furthermore, evidence of non-pharmacological interventions for both anxiety and pain management is limited. Music has been shown to be effective at reducing anxiety and pain in a variety of contexts, however to our knowledge, its effectiveness for anxiety and pain relief during the IUD insertion procedure has not been formally examined. This study will therefore examine the effectiveness of listening to music on anxiety and pain during IUD insertion.

NCT ID: NCT03827525 Not yet recruiting - Anxiety Clinical Trials

Cognitive and Behavioral Therapy of Anxiety in Williams Syndrome

WILL-COPE
Start date: February 2019
Phase:
Study type: Observational

Patients with Williams-Beuren syndrome are eight times more likely to suffer from anxiety compared to the general population. Few therapeutic solutions are proposed to these patients. The objective of this research is to validate a cognitive and behavioral therapy anxiety protocol for patients with this syndrome.

NCT ID: NCT03825978 Completed - Anxiety Clinical Trials

Efficacy of Counseling for Prenatal Screening and Diagnostic Tests on Pregnant Women: Randomised Controlled Study

Start date: June 10, 2017
Phase: N/A
Study type: Interventional

The aim of this study was to evaluate the effect of counseling for prenatal screening and diagnostic tests on pregnant women's decisional conflict, being sure of the decision, anxiety levels, and attitudes towards the tests. This prospective randomized controlled intervention study was conducted between the dates June 2017 and March 2018 in a training and research hospital, department of obstetrics and gynecology. The sample of the study consisted of 210 pregnant women who took antenatal care between the 8-11th gestational weeks of whom 112 were in the intervention group and 98 were in the control group. The data were collected by using Data Collection Form, The State-Trait Anxiety Inventory (STAI I-II), Decisional Conflict Scale (DCS), Sure Scale (SURE), Knowledge Evaluation Form about Prenatal Genetic Screening and Diagnostic Tests, Prenatal Counseling Satisfaction Form, Decision Satisfaction Form and Attitudes towards the tests Scale. The study carried out in two stages. In the first stage; women's data were collected before and after participating prenatal genetic screening tests. After the results of the screening test were taken, the data were collected again. Counseling was provided for 112 pregnant women about prenatal screening and diagnostic tests before participating tests. Routine clinical information was given for 98 pregnant women who were in control group. Both groups were pre and post-tested at the same times. In the second phase, pregnant women who had diagnostic tests were evaluated. Counseling for prenatal genetic diagnosis tests was provided for 31 pregnant women in inetervetion group women and routine clinical information was providen for 26 pregnant women who were in control group. Data were collected again with data collection tools before and after the diagnostic test.

NCT ID: NCT03823456 Recruiting - Depression Clinical Trials

Self-acupressure for Cancer-related Symptom Cluster of Insomnia, Depression, and Anxiety: a Feasibility Study

Start date: December 4, 2018
Phase: N/A
Study type: Interventional

Aim: To assess the acceptability and make estimations about the effectiveness of using self-acupressure to manage insomnia, depression, and anxiety in cancer patients undergoing chemotherapy. Study design: three-arms randomized sham-controlled trial. Participants will be assigned to the true self-acupressure group, sham acupressure group, or enhanced standard care group, with a ratio of 1:1:1 using block randomize. Participants: patients receiving chemotherapy. 114 patients will be recruited to the study. Inclusion criteria: Undergoing chemotherapy currently, Age 20 - 84 years' old, able to read and write Vietnamese, Karnofsky score ≥ 80, Insomnia Severity Index (ISI) score ≥ 11, Anxiety score measured by The Hospital Anxiety and Depression Scale (HADS) ≥ 8 and Depression score measured by HADS ≥ 8 Exclusion criteria: Patients are excluded from the trial if they are unable to understand or cooperate with study procedures, receiving other cancer treatments (e.g., radiotherapy, hormonal therapy) at the same time as receiving chemotherapy and during the period of their involvement in the trial, participating in other research studies which may have interacted with the current trial or affect insomnia, depression, anxiety perception, having difficulties or are unable to practice self-acupressure by themselves, are receiving insomnia or depression/anxiety treatment currently. Interventions Self-administered acupressure training section Participants in the true or sham self-acupressure groups will receive a self-administered acupressure training section based on their group assignment. Then, they will be requested to practice acupressure at home for 4 weeks. Patient leaflet All of the participants in three groups will receive a patient leaflet with tips to manage insomnia, depression, and anxiety. Weekly telephone reminder will be made to follow-up participants in all groups. Outcome measurement The recruitment rate, consent rate, refusal rate, attrition rate, adherence rate will be calculated. The acceptability of the intervention will be measured by the Intervention Rating Profile - 15. The ISI, The HADS, and The Functional Assessment of Cancer Therapy-General will be used to evaluate the effects of self-acupressure on the severity of insomnia, depression, anxiety. Others sleep parameters and adverse events associated with self-acupressure will be recorded.